Creating standards for accurate COVID-19 testing
Development and Characterization of Phage QBeta-Based SARS-CoV-2 RT-qPCR Assay Calibration Standards
This study is working on creating better tools for COVID-19 testing to help doctors know how much virus is in a person's body, which can improve diagnosis and treatment, especially for those with weakened immune systems.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10993686 on NIH RePORTER |
What this research studies
This research focuses on developing calibration standards for SARS-CoV-2 RT-qPCR assays, which are crucial for diagnosing COVID-19. By establishing a reliable method to convert cycle threshold values into accurate viral load measurements, the project aims to improve the accuracy of COVID-19 testing. This will help determine if individuals are infectious, assess treatment effectiveness in immunocompromised patients, and differentiate between current infections and residual viral RNA. The goal is to make these standards affordable and accessible for diagnostic and research laboratories.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals undergoing COVID-19 testing, especially those with varying viral loads or immunocompromised conditions.
Not a fit: Patients who are not being tested for COVID-19 or those who have already recovered from the virus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate COVID-19 testing, improving patient management and treatment outcomes.
How similar studies have performed: Other research has successfully developed calibration standards for various diagnostic assays, indicating a promising potential for this approach in COVID-19 testing.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Kirby, James E — Beth Israel Deaconess Medical Center
- Study coordinator: Kirby, James E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.